english.prescrire.org > Spotlight > 100 most recent > Anti-competitive practices: a very "inventive" pharmaceutical industry

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Anti-competitive practices: a very "inventive" pharmaceutical industry

 Outlook  A total of €780 million in fines was imposed in the European Union over the period 2018-2022. More than half of this sum related to a case in France that has been appealed by the companies concerned.
Full article available for download (FREE)

 ©Prescrire 1 September 2025

Source: "Anti-competitive practices: a very 'inventive' pharmaceutical industry" Prescrire Int 2025; 34 (273): 223. FREE.

Filet

Enjoy full access to Prescrire International, and support independent information

 

Share
Share on  Facebook  
 
 
See also:

"Pricing of new drugs:
deadlock"
Prescrire Int 2025;
34 (273): 199.
FREE
 
 
Antineoplastic drugs
that do not represent
a therapeutic advance:
still highly profitable"
Prescrire Int 2025;
34 (273): 222-223.
FREE